Evidence map›Paper›PMID 41728503›Full record

ArticleCureus2026

Misleading Presentation of Multilesional Benign Pathologies in the Breast: A Diagnostic Challenge.

A Lezith Marroquin Rodriguez, Perla Hernandez, Estefania Gomez-Charnichart, Ana Guadalupe Zapata Castillo, Javier Mohamed Reza de Leon, Luis A Solis

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A Lezith Marroquin RodriguezBreast Cancer Detection and Diagnostic Center - Nuevo Leon, Hospital Regional ISSSTE, Monterrey, MEX.
Perla HernandezBreast Cancer Detection and Diagnostic Center - Nuevo Leon, Hospital Regional ISSSTE, Monterrey, MEX.
Estefania Gomez-CharnichartSurgery, Hospital Regional ISSSTE, Monterrey, MEX.
Ana Guadalupe Zapata CastilloRadiology, Hospital Regional ISSSTE, Monterrey, MEX.
Javier Mohamed Reza de LeonRadiology, Hospital Regional ISSSTE, Monterrey, MEX.
Luis A SolisRadiology, Hospital Regional ISSSTE, Monterrey, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 41-year-old female presented to our service, referred by the oncology department for evaluation of multiple nodules in the right breast. Upon questioning, the patient reported that she had sought consultation for multiple dermal lesions present for approximately 20 years in the right areolar region. However, upon examination, the physician noted palpable breast nodules and requested imaging studies for better characterization. An excisional biopsy of one of the breast nodules was subsequently performed for histopathological analysis. Because the patient's primary concern was the longstanding dermal lesions, one of these was also excised and submitted for histopathological evaluation. The breast nodule was diagnosed as fibrocystic mastopathy, while the dermal lesion was identified as a keloid scar. Comprehensive multimodality breast imaging, including mammography, ultrasound, and contrast-enhanced MRI, is essential for accurate characterization of palpable nodules, particularly when clinical findings and patient-reported symptoms are discordant. Radiologic-pathologic correlation is especially critical in the presence of multiple lesions of differing tissue origins to ensure accurate diagnosis and appropriate management of both dermal and breast parenchymal conditions.

Indexed as

benign pathologyfibrocystic mastopathyhormonal influencekeloid scarscar formation

Identifiers

PMID41728503
PMCPMC12918421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.